KDM1A and neoplasm: Since LSD1 functions as a potent inhibitor of anti-tumor immunity [75], it is not surprising that LSD1 inhibitors promote anti-tumor immunity and improve the therapeutic efficacy of immune checkpoint blockade in various tumor models [75, 76].